Latest News

Below you will find our latest blog posts, press releases, alerts, newsflashes, infobytes, case studies and webinars. Happy reading!
bt_bb_section_bottom_section_coverage_image
https://www.crs.co.za/wp-content/uploads/2021/11/mandatory-vaccines.jpg

The legal concerns around mandatory vaccines in the SA workplace Government is working hard to reach its target of vaccinating 67% of the country’s population by the end of this year. Many local companies have also instituted vaccine mandates for employees who want to return to the office. Ian McAlister, General Manager at CRS Technologies,...

https://www.crs.co.za/wp-content/uploads/2021/08/vaccine-naysayer.jpg

Vaccine taker vs vaccine naysayer: What does this mean for the workplace? The line between employee rights and workplace safety is becoming increasingly blurred in a world where vax meets anti-vax  The COVID-19 vaccine debate has never been hotter. Take it, say the medical professionals and the vaccine believers. No, say the vaccine debaters and...

https://www.crs.co.za/wp-content/uploads/2020/10/retrenchment-pack-crs-690-by-460.jpg

Leverage the experience of trained HR and legal experts to manage workplace regulations and legalities without the hassle Is your organisation and workforce COVID-19 ready? Does your human resources team know the ins and outs of the Protection of Personal Information Act (POPIA)? Have you developed a consistent retrenchment package that adheres to recent regulatory changes? For most...

https://www.crs.co.za/wp-content/uploads/2021/02/Newsflash-Header-Horizontal.jpg

MARCH 2020 – SOUTH AFRICA NOTICE ON COMPENSATION FOR OCCUPATIONALLY ACQUIRED NOVEL CORONA VIRUS DISEASE It is important that employers note the following: Notice published regarding occupationally acquired novel Corona virus disease On Friday, 20 March the Department of Labour published a notice on the compensation for occupationally acquired novel Coronavirus disease (COVID-19) in terms...

We use cookies to ensure that we give you the best experience on our website.